Cardlytics, Inc. Stockholders Equity

Quick Answer

Cardlytics, Inc. reported Stockholders Equity of -$6.51 million for fiscal year 2025.

Cardlytics, Inc. Stockholders Equity — Annual History

Fiscal Year Stockholders Equity YoY Change
2025 -$6.51M -109.3%
2024 $69.99M -48.1%
2023 $134.80M -36.3%
2022 $211.60M -69.4%
2021 $690.70M +339.4%
2020 $157.19M +9.7%
2019 $143.27M +175.6%
2018 $51.98M +124.9%
2017 -$208.69M +3.8%
2016 -$216.84M -33.7%
2015 -$162.16M

Quarterly Stockholders Equity

Quarter Ending Stockholders Equity YoY QoQ
September 30, 2025 -$4.70M -106.7% -108.0%
June 30, 2025 $58.71M -72.0% -8.4%
March 31, 2025 $64.09M -67.8% -8.4%
December 31, 2024 $69.99M -48.1% +0.4%
September 30, 2024 $69.70M -69.1% -66.8%
June 30, 2024 $210.03M -11.0% +5.5%
March 31, 2024 $199.14M -14.3% +47.7%
December 31, 2023 $134.80M -36.3% -40.2%
  • Cardlytics, Inc. showed a decrease of -109.3% in Stockholders Equity compared to the prior fiscal year.
  • Over the 2015–2025 period, Cardlytics, Inc.’s stockholders equity has grown by 96.0% (from -$162.16 million to -$6.51 million).
  • The most recent figure is from Cardlytics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 4, 2026.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment